Literature DB >> 2846636

Evaluation of Abbott CMV-M enzyme immunoassay for detection of cytomegalovirus immunoglobulin M antibody.

L Schaefer1, A Cesario, G Demmler, S Plotkin, S Stagno, C Elrod, J Ringler, N Tustin.   

Abstract

The Abbott CMV-M enzyme immunoassay (EIA) for the qualitative determination of immunoglobulin M (IgM) antibody to cytomegalovirus in human serum was compared with the indirect fluorescent-antibody (IFA) test on 338 human serum specimens. Discordant specimens were evaluated by IFA following isolation of IgM fractions. Discordant specimens remaining after IFA testing were evaluated by an IgM-specific EIA (CYTOMEGELISA M; M.A. Bioproducts). After resolution of discordant specimens, the CMV-M EIA was 94.7% sensitive and 99.1% specific.

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 2846636      PMCID： PMC266812          DOI： 10.1128/jcm.26.10.2041-2043.1988

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  6 in total

1.  Clinical trials of immunization with the Towne 125 strain of human cytomegalovirus.

Authors:  S A Plotkin; J Farquhar; E Horberger
Journal:  J Infect Dis       Date:  1976-11       Impact factor: 5.226

2.  Nosocomial transmission of cytomegalovirus.

Authors:  S P Adler
Journal:  Pediatr Infect Dis       Date:  1986 Mar-Apr

3.  Evaluation of a radioimmunoassay for IgM-class antibodies against cytomegalovirus.

Authors:  H O Kangro
Journal:  Br J Exp Pathol       Date:  1980-10

4.  Antibody response to cytomegalovirus after renal transplantation: comparison of patients with primary and recurrent infections.

Authors:  R F Pass; P D Griffiths; A M August
Journal:  J Infect Dis       Date:  1983-01       Impact factor: 5.226

5.  Detection of IgM antibodies against cytomegalovirus: comparison of two radioimmunoassays, enzyme-linked immunosorbent assay and immunofluorescent antibody test.

Authors:  H O Kangro; J C Booth; T M Bakir; Y Tryhorn; S Sutherland
Journal:  J Med Virol       Date:  1984       Impact factor: 2.327

6.  Virus-specific IgG and IgM antibodies in normal and immunocompromised subjects infected with cytomegalovirus.

Authors:  L Rasmussen; D Kelsall; R Nelson; W Carney; M Hirsch; D Winston; J Preiksaitis; T C Merigan
Journal:  J Infect Dis       Date:  1982-02       Impact factor: 5.226
  6 in total
  2 in total

1.  Results of a quality assurance program for detection of cytomegalovirus infection in the pediatric pulmonary and cardiovascular complications of vertically transmitted human immunodeficiency virus infection study.

Authors:  G J Demmler; A Istas; K A Easley; A Kovacs
Journal:  J Clin Microbiol       Date:  2000-11       Impact factor: 5.948

2.  Maternal cytomegalovirus immune status and hearing loss outcomes in congenital cytomegalovirus-infected offspring.

Authors:  Gail J Demmler-Harrison; Jerry A Miller
Journal:  PLoS One       Date:  2020-10-09       Impact factor: 3.240
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.